Abstract
Predictive medicine is a new philosophy in healthcare and an attractive subject for currently initiated research activities aimed at a potential application of innovative biotechnologies in the prediction of human pathologies, a development of well-timed prevention and individual therapy-planning. Diabetes care is one of the best examples of an absolute necessity for well-timed prediction, prevention and personalized treatment. Diabetes mellitus frequently results in diverse severe complications, such as retinopathy, nephropathy, silent ischemia, dementia, and cancer – the cascade of chronic complications appearing as “domino-effect”. Promising approaches of differential plasma proteome, detection of circulating nucleic acids and gene expression profiling in circulating leukocytes are currently discussed for development of potent diagnostic, prognostic and therapeutic targets. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease. High potential of an application of novel gene therapy approaches in diabetes care is expected for such advanced technologies as gene repair by gene replacement therapies.
Keywords: Metabolic syndrome, advanced technologies, novel targets, early / predictive diagnosis, drug delivery, gene therapy
Infectious Disorders - Drug Targets
Title: Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment
Volume: 8 Issue: 2
Author(s): Olga Golubnitschaja
Affiliation:
Keywords: Metabolic syndrome, advanced technologies, novel targets, early / predictive diagnosis, drug delivery, gene therapy
Abstract: Predictive medicine is a new philosophy in healthcare and an attractive subject for currently initiated research activities aimed at a potential application of innovative biotechnologies in the prediction of human pathologies, a development of well-timed prevention and individual therapy-planning. Diabetes care is one of the best examples of an absolute necessity for well-timed prediction, prevention and personalized treatment. Diabetes mellitus frequently results in diverse severe complications, such as retinopathy, nephropathy, silent ischemia, dementia, and cancer – the cascade of chronic complications appearing as “domino-effect”. Promising approaches of differential plasma proteome, detection of circulating nucleic acids and gene expression profiling in circulating leukocytes are currently discussed for development of potent diagnostic, prognostic and therapeutic targets. Minimal invasive insulin administration approaches and/or improvement of pancreatic activity in own insulin production is the main goal of novel drug delivery systems highly desirable for advanced treatment of diabetic patients with both type 1 and type 2 of the disease. High potential of an application of novel gene therapy approaches in diabetes care is expected for such advanced technologies as gene repair by gene replacement therapies.
Export Options
About this article
Cite this article as:
Golubnitschaja Olga, Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment, Infectious Disorders - Drug Targets 2008; 8 (2) . https://dx.doi.org/10.2174/187152608784746538
DOI https://dx.doi.org/10.2174/187152608784746538 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Atrial Tachycardias Occurring Late After Open Heart Surgery
Current Cardiology Reviews Local Delivery of Therapeutics for Percutaneous Coronary Intervention
Current Drug Delivery Recent Advancements in Carbon Nanofiber and Carbon Nanotube Applications in Drug Delivery and Tissue Engineering
Current Pharmaceutical Design SemanticDB: A Semantic Web Infrastructure for Clinical Research and Quality Reporting
Current Bioinformatics Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Surgical or Interventional Revascularization in Diabetic Patients with Coronary Artery Disease?
Current Diabetes Reviews Dynamic Ventricular Repolarisation: From Physiology to Prognosis
Current Cardiology Reviews Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Microbubble: A Potential Ultrasound Tool in Molecular Imaging
Current Pharmaceutical Biotechnology Serotonin as a Modulator of Glutamate- and GABA-Mediated Neurotransmission: Implications in Physiological Functions and in Pathology
Current Neuropharmacology Lipoproteins in Atherosclerosis Process
Current Medicinal Chemistry An Evaluation of the Efficacy of Local Hemostatic Measures in Dental Patients Taking Oral Anticoagulants: A Critical Review of the Literature Over the Past Two Decades
Current Clinical Pharmacology Artificial Organs: A New Option for Treating Osteoarthritis
Current Drug Delivery A Timely Review of State-of-the-Art Chronopharmaceuticals Synchronized with Biological Rhythms
Current Drug Delivery Effects of Altered Plasminogen Activator Inhibitor-1 Expression on Cardiovascular Disease
Current Drug Targets Editorial (Thematic Issue: Endothelium: A Target for Therapeutic Intervention)
Current Vascular Pharmacology Editorial (Heart Failure: The Need for Global Health Perspective)
Current Cardiology Reviews Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Oral Infection and Vascular Disease
Vascular Disease Prevention (Discontinued) Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter
Current Radiopharmaceuticals